Skip to content

Kailera Therapeutics, Inc.

KLRA · XNAS

CIK 2096997fmd_0JAZ0J6XV5YD0FTF90R19CDBK1Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 6 periods

Proof

Every number on this company page links to a proof: the filing it came from, the XBRL tag, the knowledge interval, and the raw facts it was built from. Hover any cell in Financials for the summary; click to open the full record.

How to read a proof

  1. Accession and form identify the filing; the SEC link opens the primary document.
  2. Tag, dimensions and decimals identify the fact within that filing.
  3. The knowledge interval says when this value became known and, if restated, when it stopped being current.
  4. Derived values list every as-reported fact in the chain.
Open Financials